"Our endeavour will be to gain market share in each of our business by doing better. Despite the near-term uncertainties related to COVID-19, we hope to be able to do better consistently," Sun Pharmaceutical Industries MD Dilip Shanghvi said in an analyst call.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eGtJbB
via IFTTT
0 comments:
Post a Comment